CLINICAL_TRIALS
trial_result
· 2018-03-23
Clinical Trial Update: Effect of Sulodexide in Early Diabetic Nephropathy [Phase 3]
Summary
Phase 3 trial of sulodexide in early diabetic nephropathy completed; results were posted in March 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Keryx Biopharmaceuticals | Conditions: Diabetic Nephropathy | Phase 3 | Status: COMPLETED | Results posted: 2018-03-23